Abstract Purpose of Review Multiple sclerosis (MS) is the most frequent neuroinflammatory
disease of the central nervous system and is commonly associated with lower urinary tract …

This is a systematic review on the treatment of lower urinary tract symptoms (LUTS) in
patients with multiple sclerosis (MS). The heterogeneity of the outcome criteria did not allow …

Multiple sclerosis (MS) is a unique neurological disease with a broad spectrum of clinical
presentations that are time-and disease course-related. Lower urinary tract symptoms …

Lower urinary tract (LUT) dysfunction is common in multiple sclerosis (MS), and has a
considerable impact on quality of life. It most often results from involvement of the spinal …

Aim Neurogenic lower urinary tract dysfunction (NLUTD) is very common in multiple
sclerosis (MS) patients. Early diagnosis and treatment are crucial to avoid irreversible …

Aims Since lower urinary tract dysfunction (LUTD) related to multiple sclerosis (MS) has a
different behavior pattern than other types of neurogenic voiding dysfunction, we aimed to …

Objective To review current management of neurogenic lower urinary tract dysfunction
(NLUTD) in MS patients and give recommendations on the joint role of the neurologist and …

Lower urinary tract (LUT) dysfunction is common in patients with multiple sclerosis and is a
major negative influence on the quality of life of these patients. The most commonly reported …

Multiple sclerosis (MS) can be a debilitating neurological condition that attributes significant
morbidity to bladder dysfunction. Although many effective treatment options exist …

Aims Lower urinary tract dysfunctions (LUTD) are very common in Multiple Sclerosis (MS),
have a significant social impact, while the organic impact is discussed. We studied urinary …